Cargando…

Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes

Background: Sclerobanding is a novel technique combining rubber band ligation with 3% polidocanol foam sclerotherapy for the treatment of hemorrhoidal disease (HD). The aim of this study is to evaluate the feasibility, safety and short-term outcomes of sclerobanding in the treatment of second- and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pata, Francesco, Bracchitta, Luigi Maria, D’Ambrosio, Giancarlo, Bracchitta, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745462/
https://www.ncbi.nlm.nih.gov/pubmed/35011962
http://dx.doi.org/10.3390/jcm11010218
_version_ 1784630351020163072
author Pata, Francesco
Bracchitta, Luigi Maria
D’Ambrosio, Giancarlo
Bracchitta, Salvatore
author_facet Pata, Francesco
Bracchitta, Luigi Maria
D’Ambrosio, Giancarlo
Bracchitta, Salvatore
author_sort Pata, Francesco
collection PubMed
description Background: Sclerobanding is a novel technique combining rubber band ligation with 3% polidocanol foam sclerotherapy for the treatment of hemorrhoidal disease (HD). The aim of this study is to evaluate the feasibility, safety and short-term outcomes of sclerobanding in the treatment of second- and third-degree HD. Methods: A retrospective analysis of second- and third-degree HD cases from November 2017 to August 2021 was performed. Patients on anticoagulants or with other HD degrees were excluded. Follow-up was conducted at 1 month, 3 months, 6 months, 1 year and then every 12 months. Results: 97 patients with second- (20 pts; 20.6%) and third-degree (77 pts; 79.4%) HD with a mean age of 52 years (20–84; SD ± 15.5) were included. Fifty-six patients were men (57.7%) and forty-one women (42.3%). Median follow-up was 13 months (1–26 months). No intraoperative adverse events or drug-related side effects occurred. Minor complications occurred in four patients (4.1%) in the first 30 postoperative days and all resolved after conservative treatment at the 3-month follow-up visit. No mortality or readmissions were observed. Conclusions: Sclerobanding is a safe technique with a low rate of minor postoperative complications. Further studies on larger samples are necessary to establish the effectiveness and long-term outcomes of the technique.
format Online
Article
Text
id pubmed-8745462
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87454622022-01-11 Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes Pata, Francesco Bracchitta, Luigi Maria D’Ambrosio, Giancarlo Bracchitta, Salvatore J Clin Med Article Background: Sclerobanding is a novel technique combining rubber band ligation with 3% polidocanol foam sclerotherapy for the treatment of hemorrhoidal disease (HD). The aim of this study is to evaluate the feasibility, safety and short-term outcomes of sclerobanding in the treatment of second- and third-degree HD. Methods: A retrospective analysis of second- and third-degree HD cases from November 2017 to August 2021 was performed. Patients on anticoagulants or with other HD degrees were excluded. Follow-up was conducted at 1 month, 3 months, 6 months, 1 year and then every 12 months. Results: 97 patients with second- (20 pts; 20.6%) and third-degree (77 pts; 79.4%) HD with a mean age of 52 years (20–84; SD ± 15.5) were included. Fifty-six patients were men (57.7%) and forty-one women (42.3%). Median follow-up was 13 months (1–26 months). No intraoperative adverse events or drug-related side effects occurred. Minor complications occurred in four patients (4.1%) in the first 30 postoperative days and all resolved after conservative treatment at the 3-month follow-up visit. No mortality or readmissions were observed. Conclusions: Sclerobanding is a safe technique with a low rate of minor postoperative complications. Further studies on larger samples are necessary to establish the effectiveness and long-term outcomes of the technique. MDPI 2021-12-31 /pmc/articles/PMC8745462/ /pubmed/35011962 http://dx.doi.org/10.3390/jcm11010218 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pata, Francesco
Bracchitta, Luigi Maria
D’Ambrosio, Giancarlo
Bracchitta, Salvatore
Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
title Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
title_full Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
title_fullStr Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
title_full_unstemmed Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
title_short Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
title_sort sclerobanding (combined rubber band ligation with 3% polidocanol foam sclerotherapy) for the treatment of second- and third-degree hemorrhoidal disease: feasibility and short-term outcomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745462/
https://www.ncbi.nlm.nih.gov/pubmed/35011962
http://dx.doi.org/10.3390/jcm11010218
work_keys_str_mv AT patafrancesco sclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomes
AT bracchittaluigimaria sclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomes
AT dambrosiogiancarlo sclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomes
AT bracchittasalvatore sclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomes